LU85755A1 - Procede de preparation de derives de la prednisone et produits intermediaires de ce procede - Google Patents

Procede de preparation de derives de la prednisone et produits intermediaires de ce procede Download PDF

Info

Publication number: LU85755A1
Authority: LU; Luxembourg
Prior art keywords: formula; products; product; iii; vii
Prior art date: 1984-02-03

Application number

LU85755A

Other languages

English (en)

French (fr)

Inventor

Michel Vivat

Jean Buendia

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-02-03

Filing date

1985-02-01

Publication date

1985-10-22

1985-02-01 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1985-10-22 Publication of LU85755A1 publication Critical patent/LU85755A1/fr

Links

238000000034 method Methods 0.000 title claims description 12
238000002360 preparation method Methods 0.000 title claims description 5
239000013067 intermediate product Substances 0.000 title description 2
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical class O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 title description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
239000000203 mixture Substances 0.000 claims description 25
-1 alkyl radical Chemical class 0.000 claims description 14
239000003795 chemical substances by application Substances 0.000 claims description 10
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 9
239000003638 chemical reducing agent Substances 0.000 claims description 9
OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 7
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
125000004432 carbon atom Chemical group C* 0.000 claims description 6
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
239000001301 oxygen Substances 0.000 claims description 5
229910052760 oxygen Inorganic materials 0.000 claims description 5
230000005587 bubbling Effects 0.000 claims description 4
125000005843 halogen group Chemical group 0.000 claims description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
238000006460 hydrolysis reaction Methods 0.000 claims description 4
229910052742 iron Inorganic materials 0.000 claims description 4
LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 claims description 4
TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 4
JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims description 4
239000004215 Carbon black (E152) Substances 0.000 claims description 3
239000007983 Tris buffer Substances 0.000 claims description 3
229940076286 cupric acetate Drugs 0.000 claims description 3
238000006297 dehydration reaction Methods 0.000 claims description 3
230000002140 halogenating effect Effects 0.000 claims description 3
229930195733 hydrocarbon Natural products 0.000 claims description 3
230000007062 hydrolysis Effects 0.000 claims description 3
150000002500 ions Chemical class 0.000 claims description 3
229910052763 palladium Inorganic materials 0.000 claims description 3
NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 2
230000018044 dehydration Effects 0.000 claims description 2
238000006735 epoxidation reaction Methods 0.000 claims description 2
WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
150000003254 radicals Chemical class 0.000 claims description 2
LUZSPGQEISANPO-UHFFFAOYSA-N butyltin Chemical compound CCCC[Sn] LUZSPGQEISANPO-UHFFFAOYSA-N 0.000 claims 1
150000004678 hydrides Chemical class 0.000 claims 1
239000000047 product Substances 0.000 description 75
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
239000003480 eluent Substances 0.000 description 7
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
239000002253 acid Substances 0.000 description 6
FDSGHYHRLSWSLQ-UHFFFAOYSA-N dichloromethane;propan-2-one Chemical compound ClCCl.CC(C)=O FDSGHYHRLSWSLQ-UHFFFAOYSA-N 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 5
230000009466 transformation Effects 0.000 description 5
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
239000012043 crude product Substances 0.000 description 4
238000001035 drying Methods 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
238000010992 reflux Methods 0.000 description 4
239000000377 silicon dioxide Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
LKQVYBSBDWEBEM-VMXHOPILSA-N (8s,9s,10r,13s,14s)-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCC=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 LKQVYBSBDWEBEM-VMXHOPILSA-N 0.000 description 3
YZZVVLUNOZJXCM-DADBAOPHSA-N (8s,9s,10r,13s,14s,17s)-17-acetyl-10,13-dimethyl-7,8,9,12,14,15,16,17-octahydro-6h-cyclopenta[a]phenanthrene-3,11-dione Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2=O YZZVVLUNOZJXCM-DADBAOPHSA-N 0.000 description 3
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
239000002585 base Substances 0.000 description 3
OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
239000001632 sodium acetate Substances 0.000 description 3
235000017281 sodium acetate Nutrition 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
239000002904 solvent Substances 0.000 description 3
QQCBOIWDENXRLP-BYZMTCBYSA-N (8s,9s,10r,13r,14s,17s)-17-ethyl-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCC=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 QQCBOIWDENXRLP-BYZMTCBYSA-N 0.000 description 2
BBIKZDFNGNLZAQ-ILUWVSRXSA-N 2-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl]propanal Chemical compound C1CC2=CCC=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(C=O)C)[C@@]1(C)CC2 BBIKZDFNGNLZAQ-ILUWVSRXSA-N 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
FAOSYNUKPVJLNZ-UHFFFAOYSA-N butylstannane Chemical compound CCCC[SnH3] FAOSYNUKPVJLNZ-UHFFFAOYSA-N 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
230000026030 halogenation Effects 0.000 description 2
238000005658 halogenation reaction Methods 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
MCUKTMRUPYXLIJ-DADBAOPHSA-N (8S,9S,10R,13S,14S,17S)-17-(N-hydroxy-C-methylcarbonimidoyl)-10,13-dimethyl-7,8,9,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthrene-3,11-dione Chemical compound CC([C@H]1CC[C@H]2[C@@H]3CCC4=CC(C=C[C@]4(C)[C@H]3C(C[C@]12C)=O)=O)=NO MCUKTMRUPYXLIJ-DADBAOPHSA-N 0.000 description 1
VLXSIHLNPYRFFN-UHFFFAOYSA-N 1,4-dioxane;methanol Chemical compound OC.C1COCCO1 VLXSIHLNPYRFFN-UHFFFAOYSA-N 0.000 description 1
VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
TWSJCJURMLDFNR-RUPOLABUSA-N 2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthren-17-yl]propanoic acid Chemical compound C1CC2=CCC=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(C)C(O)=O)[C@@]1(C)CC2 TWSJCJURMLDFNR-RUPOLABUSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical class OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 1
RIEYKVLCMDCSJY-UHFFFAOYSA-N acetic acid;n,n-dimethylformamide;hydrate Chemical compound O.CC(O)=O.CN(C)C=O RIEYKVLCMDCSJY-UHFFFAOYSA-N 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical group 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
239000011260 aqueous acid Substances 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
238000005899 aromatization reaction Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000031709 bromination Effects 0.000 description 1
238000005893 bromination reaction Methods 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
BESNXTPHHWCFPI-UHFFFAOYSA-N copper;triphenylphosphane Chemical compound [Cu].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 BESNXTPHHWCFPI-UHFFFAOYSA-N 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000009472 formulation Methods 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
239000005457 ice water Substances 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
150000004965 peroxy acids Chemical class 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
229960004618 prednisone Drugs 0.000 description 1
150000003118 prednisones Chemical class 0.000 description 1
XYKIUTSFQGXHOW-UHFFFAOYSA-N propan-2-one;toluene Chemical compound CC(C)=O.CC1=CC=CC=C1 XYKIUTSFQGXHOW-UHFFFAOYSA-N 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000010517 secondary reaction Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
FFGPINDAFWSJOS-UHFFFAOYSA-M sodium acetic acid acetate hydrate Chemical compound O.[Na+].CC(O)=O.CC([O-])=O FFGPINDAFWSJOS-UHFFFAOYSA-M 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
235000019345 sodium thiosulphate Nutrition 0.000 description 1
239000000126 substance Substances 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
229960001124 trientine Drugs 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

LU85755A 1984-02-03 1985-02-01 Procede de preparation de derives de la prednisone et produits intermediaires de ce procede LU85755A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8401684		1984-02-03
FR848401684A FR2559156B1 (fr)	1984-02-03	1984-02-03	Procede de preparation de derives de la prednisone et produits intermediaires de ce procede

Publications (1)

Publication Number	Publication Date
LU85755A1 true LU85755A1 (fr)	1985-10-22

Family

ID=9300741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU85755A LU85755A1 (fr)	1984-02-03	1985-02-01	Procede de preparation de derives de la prednisone et produits intermediaires de ce procede

Country Status (14)

Country	Link
US (1)	US4601854A (de)
JP (1)	JPS60237096A (de)
AT (1)	AT393683B (de)
BE (1)	BE901627A (de)
CA (1)	CA1225635A (de)
CH (1)	CH662571A5 (de)
DE (1)	DE3503704C2 (de)
FR (1)	FR2559156B1 (de)
GB (1)	GB2153357B (de)
HU (1)	HU191771B (de)
IT (1)	IT1182168B (de)
LU (1)	LU85755A1 (de)
NL (1)	NL194613C (de)
SE (1)	SE8500462L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04316593A (ja) *	1991-02-21	1992-11-06	Japan Tobacco Inc	Ｄ−アロサンの製造方法
CN108014117A (zh) *	2017-05-19	2018-05-11	南开大学	糖皮质激素受体的小分子拮抗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1158492A (en) *	1966-02-09	1969-07-16	Boots Pure Drug Co Ltd	Improvements in Acylated Steroids
CH490362A (de) *	1967-04-03	1970-05-15	Upjohn Co	Verfahren zur Herstellung von 20-Ketosteroidverbindungen
YU41412B (en) *	1978-08-15	1987-04-30	Gist Brocades Nv	Process for obtaining 17 beta-hydroxy -3-dxo-17 alpha-pregn-4-en-21-carboxylic acid
HU179980B (en) *	1979-12-28	1983-01-28	Gyogyszerkutato Intezet	Process for preparing substituted steroid-spiro-oxazolidinone derivatives
FR2493324B1 (de) *	1980-11-05	1983-01-21	Roussel Uclaf
JPS5788198A (en) *	1980-11-21	1982-06-01	Mitsubishi Chem Ind Ltd	Synthetic intermediate of corticoids

1984
- 1984-02-03 FR FR848401684A patent/FR2559156B1/fr not_active Expired
1985
- 1985-01-28 US US06/695,485 patent/US4601854A/en not_active Expired - Lifetime
- 1985-02-01 SE SE8500462A patent/SE8500462L/ not_active Application Discontinuation
- 1985-02-01 CA CA000473406A patent/CA1225635A/fr not_active Expired
- 1985-02-01 LU LU85755A patent/LU85755A1/fr unknown
- 1985-02-01 CH CH474/85A patent/CH662571A5/fr not_active IP Right Cessation
- 1985-02-01 JP JP60016711A patent/JPS60237096A/ja not_active Withdrawn
- 1985-02-01 IT IT47630/85A patent/IT1182168B/it active
- 1985-02-01 HU HU85399A patent/HU191771B/hu not_active IP Right Cessation
- 1985-02-01 BE BE0/214432A patent/BE901627A/fr not_active IP Right Cessation
- 1985-02-04 DE DE3503704A patent/DE3503704C2/de not_active Expired - Fee Related
- 1985-02-04 NL NL8500297A patent/NL194613C/nl not_active IP Right Cessation
- 1985-02-04 GB GB08502765A patent/GB2153357B/en not_active Expired
- 1985-02-04 AT AT0031885A patent/AT393683B/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE3503704A1 (de)	1985-08-08
NL194613B (nl)	2002-05-01
IT8547630A0 (it)	1985-02-01
CA1225635A (fr)	1987-08-18
GB2153357B (en)	1988-04-07
NL8500297A (nl)	1985-09-02
IT1182168B (it)	1987-09-30
GB8502765D0 (en)	1985-03-06
BE901627A (fr)	1985-08-01
FR2559156B1 (fr)	1989-03-24
SE8500462D0 (sv)	1985-02-01
CH662571A5 (fr)	1987-10-15
JPS60237096A (ja)	1985-11-25
GB2153357A (en)	1985-08-21
DE3503704C2 (de)	1994-06-30
NL194613C (nl)	2002-09-03
US4601854A (en)	1986-07-22
IT8547630A1 (it)	1986-08-01
AT393683B (de)	1991-11-25
SE8500462L (sv)	1985-08-04
FR2559156A1 (fr)	1985-08-09
HUT37630A (en)	1986-01-23
HU191771B (en)	1987-04-28
ATA31885A (de)	1991-05-15

Publication	Publication Date	Title
FR2577556A1 (fr)	1986-08-22	Derives 4-substitues d'androst-4-ene-3, 17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication
EP0049555B1 (de)	1984-02-22	Derivate von 2-Trifluormethyl-4-hydroxy-3-chinolin-carbonsäuren und Verfahren zu ihrer Herstellung
EP0610138B1 (de)	1996-07-31	Neues Verfahren zur Herstellung von 6alpha, 9alphadifluoro-Sterioden und Zwischenprodukte davon
EP0056000B1 (de)	1984-09-26	17-(Alkoxycarbonyl)(formamid)methylen-Steroidderivate und ihre Herstellung
CH652726A5 (fr)	1985-11-29	Derives steroides 17-oxazolines, leur procede de preparation et leur utilisation a la preparation de corticosteroides.
EP0001029B1 (de)	1982-09-01	Verfahren zur Herstellung von Steroid-Derivaten die in Stellung 3 eine Oximgruppe enthalten
LU85755A1 (fr)	1985-10-22	Procede de preparation de derives de la prednisone et produits intermediaires de ce procede
CA2113404C (fr)	2004-10-19	Derives 17,20-epoxydes du pregnane, leur preparation, leur application a la preparation de derives cortisoniques et intermediaires
CA1231939A (fr)	1988-01-26	PROCEDE DE PREPARATION DE DERIVES DE LA SERIE DE LA 17.alpha.-HYDROXY 19-NOR-PROGESTERONE
CA1140110A (fr)	1983-01-25	Procede de preparation de nouveaux derives de l'androst-4-ene
CA1146531A (fr)	1983-05-17	Procede de preparation de nouveaux derives 2,2- dimethyl 19-nor steroides
FR2620708A1 (fr)	1989-03-24	Nouveaux produits industriels, leur procede de preparation et leur application
EP0058097B1 (de)	1984-07-25	Verfahren zur Herstellung von 17-alpha-Hydroxy-17beta-hydroxyacetyl-Steroiden und die erhaltenen entsprechenden Zwischenprodukte
CA1096372A (fr)	1981-02-24	Procede de preparation de nouveaux 2,2-dimethyl 19- nor steroides
EP0000300A1 (de)	1979-01-10	Substituierte Estra-1,3,5(10),6-tetraene, Verfahren zur Herstellung und Verwendung in der Synthese von Tritium markierten Steroiden
EP0128839A2 (de)	1984-12-19	Radioaktive Steroide, ihre Herstellung, Zwischenprodukte, ihre Anwendung zur Hervorhebung der Glucocorticoidrezeptoren und zur Bestimmung der Zahl der Bindungsstellen
CH629823A5 (fr)	1982-05-14	Derives steroides substitues en 11beta et leur procede de preparation.
EP0184572B1 (de)	1990-01-17	Verfahren zur Herstellung von alpha-Hydroxyalkancarbonsäuren
EP0702025B1 (de)	2001-12-19	Verfahren zur Herstellung 17beta-carboxy Steroidderivate und neue Zwischenprodukte
EP0194945B1 (de)	1988-11-02	Thiophenessigsäurederivate, Verfahren zu deren Herstellung, erhaltene Zwischenprodukte, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen
CH651055A5 (fr)	1985-08-30	Procede de preparation de steroides 3-amines et de leurs sels.
CH646983A5 (fr)	1984-12-28	Derives acetyleniques chlores de l'androst-4-ene, leur preparation et medicaments les renfermant.
FR2498608A2 (fr)	1982-07-30	Nouveaux derives 17/(hydroxymethyl) (formamide) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
CH629826A5 (en)	1982-05-14	Steroids, process for preparing them and their use in the synthesis of tritium-labelled steroids
CH633564A5 (fr)	1982-12-15	Derives du pregn 4-ene, procede de preparation et compositions pharmaceutiques.